Accounting giant PricewaterhouseCoopers (PwC) is speaking out against the escalating costs of certain prescription medications, labeling them a "cultural phenomenon" that's driving up healthcare expenses. In a recent statement, the Big Four firm expressed concerns that the high prices of certain medications are not only unsustainable but also have a disproportionate impact on vulnerable populations. PwC's comments come as the global pharmaceutical industry continues to face scrutiny over its pricing practices, with many countries seeking ways to reduce the burden on their healthcare systems. As the debate over medication costs intensifies, PwC's remarks are likely to fuel the conversation about the need for more affordable and accessible healthcare options.
Big Four accountancy balks at high cost of medication it says has become ‘cultural phenomenon’
